A detailed history of Advisors Asset Management, Inc. transactions in Organon & Co. stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 660,564 shares of OGN stock, worth $9.63 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
660,564
Previous 640,906 3.07%
Holding current value
$9.63 Million
Previous $13.3 Million 4.75%
% of portfolio
0.24%
Previous 0.27%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$18.65 - $23.03 $366,621 - $452,723
19,658 Added 3.07%
660,564 $12.6 Million
Q2 2024

Aug 14, 2024

BUY
$17.45 - $21.96 $476,280 - $599,376
27,294 Added 4.45%
640,906 $13.3 Million
Q1 2024

May 14, 2024

BUY
$13.78 - $18.8 $960,286 - $1.31 Million
69,687 Added 12.81%
613,612 $11.5 Million
Q4 2023

Feb 14, 2024

BUY
$10.95 - $17.32 $2.15 Million - $3.4 Million
196,363 Added 56.5%
543,925 $7.84 Million
Q2 2023

Aug 14, 2023

BUY
$19.27 - $24.63 $2.04 Million - $2.6 Million
105,721 Added 43.72%
347,562 $7.23 Million
Q1 2023

May 12, 2023

BUY
$21.42 - $32.08 $2.05 Million - $3.07 Million
95,754 Added 65.55%
241,841 $5.69 Million
Q3 2022

Nov 08, 2022

BUY
$23.4 - $34.25 $1.11 Million - $1.62 Million
47,355 Added 301.32%
63,071 $1.48 Million
Q2 2022

Aug 08, 2022

SELL
$31.66 - $38.9 $392,900 - $482,749
-12,410 Reduced 44.12%
15,716 $530,000
Q1 2022

May 17, 2022

SELL
$30.45 - $39.36 $389,364 - $503,296
-12,787 Reduced 31.25%
28,126 $982,000
Q4 2021

Feb 15, 2022

SELL
$28.67 - $37.13 $224,285 - $290,467
-7,823 Reduced 16.05%
40,913 $1.25 Million
Q3 2021

Nov 12, 2021

SELL
$28.63 - $35.64 $70,744 - $88,066
-2,471 Reduced 4.83%
48,736 $1.6 Million
Q2 2021

Jul 30, 2021

BUY
$28.45 - $38.0 $1.46 Million - $1.95 Million
51,207 New
51,207 $1.55 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.71B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Advisors Asset Management, Inc. Portfolio

Follow Advisors Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.